166 related articles for article (PubMed ID: 18831698)
1. Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
Remtulla RA; Decker CF
Clin Infect Dis; 2008 Nov; 47(9):1233-4; author reply 1234. PubMed ID: 18831698
[No Abstract] [Full Text] [Related]
2. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
3. Severe hepatic failure related to nevirapine treatment.
Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
[No Abstract] [Full Text] [Related]
4. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
[No Abstract] [Full Text] [Related]
5. Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.
Merchante N; Pérez-Camacho I; Mira JA; Rivero A; Macías J; Camacho A; Gómez-Mateos J; García-Lázaro M; Torre-Cisneros J; Pineda JA;
Antivir Ther; 2010; 15(5):753-63. PubMed ID: 20710057
[TBL] [Abstract][Full Text] [Related]
6. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
Dieterich DT
AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
[TBL] [Abstract][Full Text] [Related]
7. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
[No Abstract] [Full Text] [Related]
8. Electrolyte disturbances may predispose nucleoside analogue-treated AIDS patients to acute renal failure.
Spichler AS; Seguro AC
Int J Infect Dis; 2004 Nov; 8(6):377-8. PubMed ID: 15494261
[No Abstract] [Full Text] [Related]
9. Toxic effects of nucleoside reverse transcriptase inhibitors on the liver. Value of electron microscopy analysis for the diagnosis of mitochondrial cytopathy.
Duong Van Huyen JP; Landau A; Piketty C; Bélair MF; Batisse D; Gonzalez-Canali G; Weiss L; Jian R; Kazatchkine MD; Bruneval P
Am J Clin Pathol; 2003 Apr; 119(4):546-55. PubMed ID: 12710127
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
Viganò A; Giacomet V
Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
[No Abstract] [Full Text] [Related]
12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia in HIV infection.
Carr A
AIDS Clin Care; 2001 Aug; 13(8):71-3, 78. PubMed ID: 11547460
[No Abstract] [Full Text] [Related]
14. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
Williams LH; Fleckman P
Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585
[No Abstract] [Full Text] [Related]
15. Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors.
Pao D; Watson C; Peters B; Lucas SB; Miller RF
Sex Transm Infect; 2001 Oct; 77(5):381-4. PubMed ID: 11588287
[No Abstract] [Full Text] [Related]
16. Death halts study.
Posit Aware; 2000; 11(1):23. PubMed ID: 11366339
[TBL] [Abstract][Full Text] [Related]
17. High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters.
Walker UA; Hoffmann C; Enters M; Thoden J; Behrens G; Mitzel SL
AIDS; 2006 Jul; 20(11):1556-8. PubMed ID: 16847413
[TBL] [Abstract][Full Text] [Related]
18. Dideoxynucleoside analogues should be used cautiously in patients with hepatic steatosis.
Zeremski M; Talal AH
Clin Infect Dis; 2006 Aug; 43(3):373-6. PubMed ID: 16804854
[No Abstract] [Full Text] [Related]
19. HIV therapy, hepatitis C virus infection, antibiotics and obesity, a mitochondria killer mix?
Côté HC; Brumme ZL; Chan JW; Guillemi S; Montaner JS; Harrigan PR
AIDS; 2006 Jun; 20(9):1343-5. PubMed ID: 16816571
[No Abstract] [Full Text] [Related]
20. Incidence and risk factors for non-nucleoside reverse transcriptase inhibitors (NNRTI)-related rash in Thai children with HIV infection.
Vemula S; Kerr S; Pancharoen C; Siripong A; Kosalaraksa P; Engchanil C; Chuamchaitrakool A; Intasan J; Lumbiganond P; Phanuphak P; Ananworanich J
J Med Assoc Thai; 2007 Nov; 90(11):2437-41. PubMed ID: 18181332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
